These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33765142)

  • 41. The microbiome and breast cancer: a review.
    Chen J; Douglass J; Prasath V; Neace M; Atrchian S; Manjili MH; Shokouhi S; Habibi M
    Breast Cancer Res Treat; 2019 Dec; 178(3):493-496. PubMed ID: 31456069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What is the collective effect of aging and HIV on the gut microbiome?
    Dillon SM; Wilson CC
    Curr Opin HIV AIDS; 2020 Mar; 15(2):94-100. PubMed ID: 31876548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modulation of the Gut Microbiota Alters the Tumour-Suppressive Efficacy of Tim-3 Pathway Blockade in a Bacterial Species- and Host Factor-Dependent Manner.
    Lee B; Lee J; Woo MY; Lee MJ; Shin HJ; Kim K; Park S
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32932843
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancing Checkpoint Inhibitor Therapy in Solid Tissue Cancers: The Role of Diet, the Microbiome & Microbiome-Derived Metabolites.
    Malczewski AB; Ketheesan N; Coward JIG; Navarro S
    Front Immunol; 2021; 12():624434. PubMed ID: 34305883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phages Enter the Fight against Colorectal Cancer.
    Kannen V; Parry L; Martin FL
    Trends Cancer; 2019 Oct; 5(10):577-579. PubMed ID: 31706504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Signatures within the esophageal microbiome are associated with host genetics, age, and disease.
    Deshpande NP; Riordan SM; Castaño-Rodríguez N; Wilkins MR; Kaakoush NO
    Microbiome; 2018 Dec; 6(1):227. PubMed ID: 30558669
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meta-analysis of 16S rRNA Microbial Data Identified Distinctive and Predictive Microbiota Dysbiosis in Colorectal Carcinoma Adjacent Tissue.
    Mo Z; Huang P; Yang C; Xiao S; Zhang G; Ling F; Li L
    mSystems; 2020 Apr; 5(2):. PubMed ID: 32291348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phage Therapy with a Focus on the Human Microbiota.
    Divya Ganeshan S; Hosseinidoust Z
    Antibiotics (Basel); 2019 Aug; 8(3):. PubMed ID: 31461990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A systematic review of gut microbiome and ocular inflammatory diseases: Are they associated?
    Shivaji S
    Indian J Ophthalmol; 2021 Mar; 69(3):535-542. PubMed ID: 33595467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of the microbiome during bacteriophage therapy in combination with systemic antibiotics to treat a case of staphylococcal device infection.
    Mu A; McDonald D; Jarmusch AK; Martino C; Brennan C; Bryant M; Humphrey GC; Toronczak J; Schwartz T; Nguyen D; Ackermann G; D'Onofrio A; Strathdee SA; Schooley RT; Dorrestein PC; Knight R; Aslam S
    Microbiome; 2021 Apr; 9(1):92. PubMed ID: 33853672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of microbial dysbiosis in carcinogenesis & cancer therapies.
    Vimal J; Himal I; Kannan S
    Indian J Med Res; 2020 Dec; 152(6):553-561. PubMed ID: 34145094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacterial community structure alterations within the colorectal cancer gut microbiome.
    Loftus M; Hassouneh SA; Yooseph S
    BMC Microbiol; 2021 Mar; 21(1):98. PubMed ID: 33789570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inter-site and interpersonal diversity of salivary and tongue microbiomes, and the effect of oral care tablets.
    Maruyama H; Masago A; Nambu T; Mashimo C; Takahashi K; Okinaga T
    F1000Res; 2020; 9():1477. PubMed ID: 33732447
    [No Abstract]   [Full Text] [Related]  

  • 56. Unexpected guests in the tumor microenvironment: microbiome in cancer.
    Wong-Rolle A; Wei HK; Zhao C; Jin C
    Protein Cell; 2021 May; 12(5):426-435. PubMed ID: 33296049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiome and pancreatic ductal adenocarcinoma.
    Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of the Microbiome in Cancer and Therapy Efficacy: Focus on Lung Cancer.
    Halley A; Leonetti A; Gregori A; Tiseo M; Deng DM; Giovannetti E; Peters GJ
    Anticancer Res; 2020 Sep; 40(9):4807-4818. PubMed ID: 32878769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Oka A; Sartor RB
    Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
    Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
    Front Immunol; 2021; 12():612826. PubMed ID: 33841394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.